Epstein Secrets

g units to third parties by Unit holders. Not sure if Joi has any Board representation. The initial Board of Managers consists of: > Ayaz Mahmud > David Levy > Mark Rioult > Jean-Marie Vallet and > Steve Yang, > DARREN K. INDYKE > DARREN K. INDYKE, PLLC > 575 Lexington Avenue, 4th Floor EFTA00689370

From: Joi Ito To: Jeffrey Epstein <[email protected]> Subject: Re: OH2 Investment Date: Mon, 17 Nov 2014 14:58:18 +0000 Thanks. I'm going through the docum

From: Joi Ito To: Jeffrey Epstein <[email protected]> Subj

ts reserved. > Begin forwarded message: » From: Joichi Ito <MI > >> Subject: OH2 Investment >> Date: Novem

the COI risk has been well-addressed and can permit this investment to go forward. Thank you for your consideration and assistance. Kind regards, David Levy, '92, SM '87, SB '87 please note The information contained in this communication is confidential, may be attorney-client privileged, may constit

ey E." <[email protected]> To: Joichi Ito <Ma> Subject: Re: update Date: Tue, 13 Jan 2015 20:49:40 +0000 ok On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito c wrote: This is the electronic nose project. Dealing with the conflict of interest issues at MIT, but I'll get an anti- dilution per below. I thin

ppearance. I will address each separately: Actual COI I double-checked and confirmed that due to the nature of the company there is no physical way Joi Ito could use his position to benefit the company (and there by himself), even if he wanted to. I say this for two reasons, both of which I believe is

"Jeffrey E." <[email protected]> To: Joichi Ito <Ma> Subject: Re: update Date: Tue, 13 Jan 2015

I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma

From: Joichi Ito < Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 20

tely: » Actual COI EFTA_R1_01300796 EFTA02338495 » I double-checked and confirmed that due to the nature of the company =here is no physical way Joi Ito could use his position to benefit the =ompany (and there by himself), even if he wanted to. » I say this for two reasons, both of which I believe i

From: Joichi Ito < Sent: Tuesday, January 13, 2015 8:59 PM To:

I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma

From: Joichi Ito Sent: Tuesday, January 13, 2015 8:59 PM To: J

ill let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok > On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito wrote: > This is the electronic nose project. Dealing with the conflict of =nterest issues at MIT, but I'll get an anti-dilution per below. = thin

tely: » Actual COI EFTA_R1_01338891 EFTA02355504 » I double-checked and confirmed that due to the nature of the company =here is no physical way Joi Ito could use his position to benefit the =ompany (and there by himself), even if he wanted to. » I say this for two reasons, both of which I believe i

OI risk has been well-addressed and can permit this investment to go for=ard. Thank you for your consideration and assistance. Kind regards, =br> David Levy, Ph.D. '92, SM '=7, SB '87 2 EFTA_R1_01646626 EFTA02513455 4> please note The information contained in this communicati=n is confidential, ma

From: jeffrey E. <[email protected]> Sent: Tuesday, January 13, 2015 8:50 PM To: Joichi Ito Subject: Re: update ok On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito > wrote: This is the electronic nose project. Dealing with the conflict of int=

the company) requires equipment MIT does not own, and the work of th= company must be performed off-campus, by definition. That is to say that =f Joi Ito were to wake up in the morning with the sole intent of affecting=something at OH2, there simply would be no path available for him to do so= That l

: Tuesday, January 13, 2015 8:50 PM To: Joichi Ito Subject: Re: update ok On Tue, Jan 13, 2015 a

I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma

ill let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok > On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito wrote: > This is the electronic nose project. Dealing with the conflict of =nterest issues at MIT, but I'll get an anti-dilution per below. = thin

tely: » Actual COI EFTA_R1_01646750 EFTA02513562 » I double-checked and confirmed that due to the nature of the company =here is no physical way Joi Ito could use his position to benefit the =ompany (and there by himself), even if he wanted to. » I say this for two reasons, both of which I believe i

From: Joichi Ito Sent: Tuesday, January 13, 2015 8:59 PM To: J

I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma

ill let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok > On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito wrote: > This is the electronic nose project. Dealing with the conflict of =nterest issues at MIT, but I'll get an anti-dilution per below. = thin

tely: » Actual COI EFTA_R1_02156618 EFTA02716629 » I double-checked and confirmed that due to the nature of the company =here is no physical way Joi Ito could use his position to benefit the =ompany (and there by himself), even if he wanted to. » I say this for two reasons, both of which I believe i

From: Joichi Ito Sent: Tuesday, January 13, 2015 8:59 PM To: J

regated proteins.4, EFTA_R1_01779011 EFTA02594854 I am very pleased that you are very interested in taking a su=-licensing of our invention. Dr. David Levy, the Managing Director o= OH2Laboratories and Dr. Marc Rioult, former MIT TLO Senior Officer will t=ke lead on the negotiation. They are very exper

16, 2014 9:41 AM To: Joi Ito Subject: Re: GPCR we should just know ore about 2nd round, so we are not dil=ted On =at, Nov 15, 2014 at 6:52 PM, Joi Ito • wrot=: Mo=e background on the science. The investment vehicle is basically a holding=company for the technology that will spin out in various appli

ent: Sunday, November 16, 2014 9:41 AM To: Joi Ito Subject: Re: GPCR we should just know ore abou